SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Liu ZM)
 

Sökning: WFRF:(Liu ZM) > Osteoprotegerin Pro...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002808naa a2200385 4500
001oai:prod.swepub.kib.ki.se:141896635
003SwePub
008240701s2019 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1418966352 URI
024a https://doi.org/10.2337/db18-10552 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Zhang, C4 aut
2451 0a Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway
264 c 2019-07-10
264 1b American Diabetes Association,c 2019
520 a Previous cross-sectional studies have established that circulating osteoprotegerin (OPG) levels are associated with nonalcoholic fatty liver disease (NAFLD). However, the role of OPG in metabolic diseases, such as diabetes and NAFLD, is still unclear. In the current study, we demonstrated that hepatic OPG expression was downregulated in NAFLD individuals and in obese mice. OPG deficiency decreased lipid accumulation and expression of CD36 and peroxisome proliferator–activated receptor-γ (PPAR-γ) in the livers of OPG−/− mice and cultured cells, respectively, whereas OPG overexpression elicited the opposite effects. The stimulatory role of OPG in lipid accumulation was blocked by CD36 inactivation in hepatocytes isolated from CD36−/− mice. The overexpression of OPG led to a decrease in extracellular signal–regulated kinase (ERK) phosphorylation in the livers of OPG−/− mice and in cultured cells, while OPG deficiency resulted in the opposite effect. The inhibition of PPAR-γ or the activation of ERK blocked the induction of CD36 expression by OPG in cultured cells. Mechanistically, OPG facilitated CD36 expression by acting on PPAR response element (PPRE) present on the CD36 promoter. Taken together, our study revealed that OPG signaling promotes liver steatosis through the ERK–PPAR-γ–CD36 pathway. The downregulation of OPG in NAFLD might be a compensatory response of the body to dampen excess hepatic fat accumulation in obesity.
700a Luo, XH4 aut
700a Chen, JR4 aut
700a Zhou, BY4 aut
700a Yang, ML4 aut
700a Liu, R4 aut
700a Liu, DF4 aut
700a Gu, HF4 aut
700a Zhu, ZM4 aut
700a Zheng, HT4 aut
700a Li, L4 aut
700a Yang, GY4 aut
773t Diabetesd : American Diabetes Associationg 68:10, s. 1902-1914q 68:10<1902-1914x 1939-327Xx 0012-1797
856u https://diabetes.diabetesjournals.org/content/diabetes/68/10/1902.full.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:141896635
8564 8u https://doi.org/10.2337/db18-1055

Hitta via bibliotek

  • Diabetes (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy